Exella GmbH & Co. KG (manufacturing of unpackaged products, primary packaging into vials and quality control of medicinal product)

The drug is used for the treatment of hyperphenylalaninemia in adults and children with phenylketonuria (PKU) or tetrahydrobiopterin (BH4) deficiency who have shown responsiveness to such treatment.

Dosage form: tablets, effervescent

ATC: A16AX07